4D Molecular Therapeutics
FDMT
$25.34
Share price
-1.17%
Change (1 day)
39.38%
Change (1 year)
Categories
Operating Margin for 4D Molecular Therapeutics (FDMT)
Operating Margin as of May 2024 (TTM): -3,517.67%
According to 4D Molecular Therapeutics's latest financial reports and stock price the company's current Operating Margin is -3,517.67%. At the end of 2021 the company had an Operating Margin of -395.37%.
Operating Margin history for 4D Molecular Therapeutics from 2020 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -395.37% | -5.07% |
| 2020 | -416.49% | -40.99% |
| 2019 | -705.78% | 944.15% |
| 2018 | -67.59% | -65.13% |
| 2017 | -193.83% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 0.00% | N/A | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.